Inactive Instrument

HEXO Corp.

HEXO

CA4283043079

Rose LifeScience Inc. acquired Québec portfolio from HEXO Corp.

May 01, 2023

Rose LifeScience Inc. acquired Québec portfolio from HEXO Corp. on May 2, 2023.

Rose LifeScience Inc. acquired Québec portfolio from HEXO Corp. on May 2, 2023.

Latest news about HEXO Corp.

Tilray Brands Launches At-The-Market Share Sale to Fund Acquisitions and Investments	05-17	MT
Tilray Brief: Announcing At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective	05-17	MT
Tilray Brief: In addition, Company no longer expects to generate positive adjusted free cash flow for the full fiscal year 2024, due to delayed timing for collecting cash on various asset sales	04-09	MT
Tilray Brief: For its fiscal year ending May 31, 2024, Company ow guiding to an Adjusted EBITDA target of US$60-$63 million	04-09	MT
Tilray Brief: Net loss per share narrowed to ($0.12) compared to ($1.90) in the prior year quarter	04-09	MT
Tilray Brief: Net loss decreased to US$105.0 million in the third quarter compared to net loss of $1.2 billion in the prior year quarter	04-09	MT
Tilray Brief: Says Achieved Q3 Net Revenue of US$188 Million, Near 30% Net Revenue Growth Over the Prior Year Quarter	04-09	MT
Tilray Brands Plans 420 Activations Across Canada, Unveils 'Celebratory Product Lineup'	04-04	MT
Tilray Brief: Announcing 420 Activations Across Canada and Unveiing "Celebratory Product Lineup"	04-04	MT
Tilray Brief: Says 10 Barrel Brewing Unveiling Newest Ready-to-Drink Canned Cocktails	03-26	MT
Tilray Brief: Announcing expansion of Redecan's product portfolio	03-21	MT
Tilray Brands Secures Approval for First Medical Cannabis Extract in Portugal	03-14	MT
Tilray Brief: Says Received Approval for First Medical Cannabis Extract in Portugal	03-14	MT
Tilray Brief: Introducing New Naturally Flavoured CBG Infused Cannabis Beverages	03-13	MT
Tilray Brief: Providing International Cannabis Update on Milestone German Cannabis Legalization	02-28	MT
Tilray Brief: Cannabis Brand Good Supply Launching New 'Juiced' Cannabis Pre-Roll Multi-Packs Across Canada	02-27	MT
Tilray Brief: Solei Brand Launching New Cannabis Infused Cold Brew Teas	02-22	MT
Tilray Brief: Says Subsidiaries Breckenridge Distillery and Breckenridge Brewery Announcing Fourth Edition of Sexy Motor Oil Whiskey and New Sexy Motor Oil Beer	01-30	MT
Tilray Brief: Says Completed Acquisition of Truss Beverage Co.	01-24	MT
Tilray Brief: Says RIFF Cannabis Brand Expanding Its Collection With New THCA 'Liquid Diamond' Vapes	01-23	MT
Tilray Brief: Says SweetWater Brewing Doubling Down on 'Gummies'	01-16	MT
Piper Sandler on Tilray Brands: 'Tough Path To Hitting F24 Guidance; Heavy Skew To F4Q24'	01-10	MT
Tilray Brands Swings to Adjusted Loss in Fiscal Q2, Net Revenue Grows; Reiterates Adjusted EBITDA Outlook for Fiscal Year 2024; Down 8.7%	01-09	MT
Tilray Brands Swings to Adjusted Loss in Fiscal Q2, Net Revenue Grows; Reiterates Adjusted EBITDA Outlook for Fiscal Year 2024	01-09	MT
Tilray Brief: Says "On Track" to Achieve US$30-$35 Million in Annual Savings related to Integration of HEXO Acquisition; Reiterates Financial Guidance for Fiscal Year 2024	01-09	MT

Hexo Corp. is a Canada-based consumer packaged goods cannabis company. The Company is engaged in cultivating, processing, packaging, and distributing cannabis products to serve the cannabis market. The Company serves the Canadian recreational market with a brand portfolio including HEXO, Redecan, UP Cannabis, Original Stash, 48North, Trail Mix, Bake Sale and Latitude brands, and the medical market in Canada and Israel. Its HEXO brand offers a range of flower strains, discreet capsules, and convenient vapes, including the HEXO FLVR lineup of flavor-first vapes.

Sector

Pharmaceuticals

More about the company

Sector Recreational Pharmaceuticals

	1st Jan change	Capi.
CURALEAF HOLDINGS, INC.	+15.43%	3.45B
TRULIEVE CANNABIS CORP.	+107.45%	1.95B
GOODNESS GROWTH HOLDINGS, INC.	+179.37%	92.19M
ACREAGE HOLDINGS, INC.	+234.62%	50.34M

Recreational Pharmaceuticals